Connective Tissue Peptides TRIZ Cases

Inhibiting the interaction between thrombospondin-1 and CD47 protects non-target tissues from radiation damage, allowing higher doses to enhance tumor ablation.

Applying controlled extensional and shear strains to prefibrillar solutions overcomes poor collagen organization in seeded cell methods.

Inhibiting Cthrc1 expression improves cardiac perfusion by promoting outward vascular remodeling without increasing myocardial oxygen demand.

Isolated anti-integrin α9 inhibitors block integrin α9β1 activity to limit brain damage following reperfusion after ischemic stroke.

Biotinylated antibodies recruit reparative cells to damaged cartilage via avidin bridges, preventing systemic side effects from non-specific drug delivery.

Engineered fibronectin type III domains with targeted residue mutations to improve protein solubility.

Mechanical stretching of an elastic substrate aligns microfibrils without cytotoxicity or invasive procedures.

Specific Xaa-Yaa-Gly peptide sequences enable self-assembly into stable, human-scale collagen assemblies without tedious crosslinking.

Segmented fibronectin domains penetrate tumor tissue to inhibit signaling while reducing side effects.

Culturing lymphocytes with specific recombinant fibronectin fragments and anti-CD3 antibodies on solid phases.

Segmented collagen-like polypeptides resolve structural control issues by localizing functional groups to termini, enabling precise assembly.

Acidic precipitation and protease digestion remove host cell contaminants to resolve low yield and high complexity in collagen purification.

Fusing elastin-like peptides extends serum half-life while maintaining therapeutic activity, resolving the trade-off between stability and efficacy.

An oxyntomodulin derivative conjugate activates GLP-1 and glucagon receptors to lower blood lipid levels.

Composite peptide structures with specific amino acid sequences enhance binding affinity to resolve low stability and short half-life in anti-VEGF therapies.

Functionalized nanoparticles bind target proteins and precipitate them via stimuli-responsive phase transitions.

Anti-HER2 antibody fused to P125A endostatin mutation directs anti-angiogenic activity to tumor sites, reducing systemic toxicity.

Detecting specific COMP neoepitopes formed by protein cleavage at defined sites differentiates pathological cartilage turnover from normal background levels.

Self-assembling peptide amphiphile nanofibers deliver nitric oxide locally to inhibit neointimal hyperplasia while reducing systemic toxicity.

Amino acid substitutions in loop regions of fibronectin type III domains increase thermal stability without reducing bacterial expression efficiency.

A synthetic binding protein monobody links targeting agents to particles or nucleic acids with controlled orientation.

Enzymatic digestion removes odor-causing impurities from avian sternum, producing undenatured collagen without chemical decolorizing agents.

Metal-ion crosslinked peptide micelles boost hydrogel strength and sustain drug release, solving weak mechanics and inefficient cargo delivery.

A homocysteine-cysteine disulfide bridge stabilizes collagen mimetic peptides by forming a covalent link between specific amino acid residues.

An elastin-like polypeptide conjugate stabilizes therapeutic agents in maternal circulation, preventing placental transfer and minimizing fetal exposure.

Recombinant gelatin particles with specific lysine residues enable controlled crosslinking, resolving natural gelatin variability and contamination risks.

A functional substance bridges retrovirus vectors and adipocytes to resolve low infectivity in gene therapy applications.

LC-MS/MS quantifies type II collagen via specific peptide segments, resolving the contradiction between measurement precision and method complexity.

Replacing collagen with synthetic elastin-like polypeptides eliminates supply chain risks while maintaining biocompatibility and bone growth support.

Targeting peptides bind to EDB-FN biomarkers to label prostate cancer cells, resolving detection precision versus cell differentiation difficulty.

Fusing endostatin with antibodies extends serum half-life and directs anti-angiogenic activity to tumors, reducing systemic toxicity.

Staged acid and enzyme liquefaction preserves protein integrity while reducing solvent use and equipment costs.

A trimeric scaffold protein fused to flexible unstructured polypeptides extends the apparent molecular weight of therapeutic agents.

Electrospun human collagen I and tropoelastin scaffolds accelerate wound closure by mimicking the extracellular matrix.

Engineered alpha-galactosidases reduce enzyme consumption during conversion of group B erythrocytes to type O cells by optimizing kinetic parameters.

Recombinant herpes viruses transduce skin cells to express functional laminin polypeptides.

Engineered Adnectins inhibit PCSK9 activity, preventing LDL receptor degradation and lowering plasma cholesterol levels.

A hyaluronic acid hydrogel incorporating laminin polypeptides and superoxide dismutase supports neuronal cell differentiation.

Covalent coupling of polyethylene glycol to specific lysine residues creates a stable endostatin analogue with extended circulation properties.

Modified peptides boost extracellular matrix protein production, addressing insufficient firmness in aging skin.

A synthetic cell culture surface formed by cross-linking functionalized pre-polymers with photo-reactive groups to support therapeutic cell growth.

Synthetic platelets mimic natural adhesion to deliver coagulation factors locally, eliminating immunogenicity while controlling bleeding.

A hyaluronic acid-binding fusion protein anchors IGF-1 in the cartilage matrix, preventing rapid clearance and sustaining therapeutic effectiveness.

Targeted knockout of endogenous proteins in CHO cells reduces host cell contamination and boosts production efficiency.

Alkaline swelling and hydrolase hydrolysis replace energy-intensive dialysis, cutting production time while maintaining collagen integrity.

Multimeric vitronectin polypeptide composition supports long-term pluripotent stem cell growth and undifferentiated state maintenance.

Culture Wharton's Jelly mesenchymal stem cells to harvest human-compatible collagen, eliminating animal-derived odors and allergic reactions.

Membrane filtration enriches whey-derived compositions with phospholipids while maintaining low microbial load without denaturing bioactive components.

Tandem VPGKG peptide binds heparin via electrostatic interaction, forming eliminable complexes that reduce hemolysis compared to protamine sulfate.

Homocysteine thiols enhance reaction kinetics to link polypeptides while minimizing radical-induced protein modification.